3Romero LC, Medrano GA, Cardenas LM, et al. An experimental model of helieoids ventricular tachycardia (torsades de pointes) [J]. Arch Inst Cardiol Mex,1987,57(1):67-72.
4Abdulrahman A, Almotrefi G. Class I antiarrhythmic drug effects on ouabain binding to guinea pig cardiac Na^+-K^+-ATPase [J]. Canandian J Physiol Pharmacol,1999,77(11):866-870.
5Su DF, Miu CY, Wang YM. Derelopment of Pharmacology[M]. Beijing:. People's Medical Publishing House,2001:126-130.
6Li BX, Yang BF, Zhou J, et al. Inhibitory effects of barbering on Ikl, Ik, and HERG channels of cardiac myocyles [J]. Acta Pharmacol Sin,2001,22 (2):125-131.
7Li GR, Yang BF, Feng JL, et al. Transmebrane Ica contributes to ratedependent changes of action potentials in human ventricular myoeytes [J]. Am J Physiol,1999,276:98-106.
8Yang BF, Xu CQ, Li YR, et al. Effects of RP58866 on transmembrane K^+ currents in mammalian ventricular myocytes [J]. Acta Pharmacol Sin, 1999,20(11):961-969.
9The Sicilian gambit.A new approach to the classification of antiarrythmic drugs based on their actions on arrhythmogenic mechanisms.Task Force of the Working Group on Arrhythmias of the European Society of Cardiology [ J ].Circulation,1991,84:1831-1851
10Wijffels MC,Kirchhof CJ,Dorland R,et al.Atrial fibrillation begets atrial fibrillation:A study in awake chronically instrumented goats[J].Circulation,1995,92:1954-1968.
